G-CSF prophylaxis of febrile neutropenia and infections after chemotherapy

被引:0
|
作者
Link, H. [1 ]
机构
[1] Westpfalz Klinikum, Innere Med Klin 1, D-67653 Kaiserslautern, Germany
来源
ONKOLOGE | 2014年 / 20卷 / 03期
关键词
D O I
10.1007/s00761-014-2649-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:268 / 270
页数:3
相关论文
共 50 条
  • [21] Febrile neutropenia does not affect collection of adequate CD34+ cells after mobilization with chemotherapy and G-CSF
    Yee, K
    Tu, JV
    MacKinnon, J
    Gandhi, M
    Stewart, AK
    Saragosa, R
    Keating, A
    Crump, M
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 310 - 310
  • [22] Febrile neutropenia primary prophylaxis with granulocyte-colony stimulating factors (G-CSF) in breast cancer
    Younis, T.
    Rayson, D.
    Skedgel, C.
    CANCER RESEARCH, 2013, 73
  • [23] G-CSF FOR FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY - REPLY
    CRAWFORD, J
    GLASPY, JA
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04): : 270 - 270
  • [24] A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia
    Lalami, Y
    Paesmans, M
    Aoun, M
    Munoz-Bermeo, R
    Reuss, K
    Cherifi, S
    Alexopoulos, CG
    Klastersky, J
    SUPPORTIVE CARE IN CANCER, 2004, 12 (10) : 725 - 730
  • [25] A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia
    Y. Lalami
    M. Paesmans
    M. Aoun
    R. Munoz-Bermeo
    K. Reuss
    S. Cherifi
    C. G. Alexopoulos
    J. Klastersky
    Supportive Care in Cancer, 2004, 12 : 725 - 730
  • [27] Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review
    T. Younis
    D. Rayson
    S. Jovanovic
    C. Skedgel
    Breast Cancer Research and Treatment, 2016, 159 : 425 - 432
  • [28] G-CSF as Secondary Prophylaxis of Febrile Neutropenia In the Management of Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Decision-Analysis
    Graczyk, Joanna
    Cheung, Matthew
    Buckstein, Rena
    Chan, Kelvin
    BLOOD, 2010, 116 (21) : 1568 - 1568
  • [29] Should ASCO re-examine the febrile neutropenia threshold for primary G-CSF prophylaxis in breast cancer?
    Younis, Tallal
    Rayson, Daniel
    Jovanovic, Sanja
    Skedgel, Chris
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review
    Younis, T.
    Rayson, D.
    Jovanovic, S.
    Skedgel, C.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (03) : 425 - 432